Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Breast cancer therapeutic agent containing 5′-hydroxy-5-nitro-indirubin-3′-oxime as active ingredient

US Patent 10285979 · Granted May 14, 2019

Assignee

Inventors

View full patent text on Google Patents →